ArticlePloS one2017

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.

Mindaugas Paužuolis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.